8-K: iAnthus Reports Q3 2025 Financials Amid Revenue Decline

iAnthus Capital Holdings, Inc. announced its third quarter 2025 financial results, showing a year-over-year decline in revenue and profitability.

Summary

• Revenue for Q3 2025 was $35.4 million, a slight increase of $0.2 million from Q2 2025 but a decrease of $4.9 million from Q3 2024.
• Gross profit stood at $15.6 million, decreasing by $0.6 million from Q2 2025 and $2.5 million from Q3 2024.
• Gross margin was 44%, a decrease of 188 basis points from Q2 2025 and 86 basis points from Q3 2024.
• Net loss improved to $12.5 million (less than $0.00 per share) from $18.7 million in Q2 2025, but was worse than the $11.6 million net loss in Q3 2024.
• Adjusted EBITDA was $2.5 million, an increase from $1.9 million in Q2 2025, but a decrease from $5.3 million in Q3 2024.
• The company received $0.3 million in Employee Retention Tax Credits (ERTCs) during Q3 2025.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to significant year-over-year declines in revenue, gross profit, gross margin, net loss (larger loss), and Adjusted EBITDA, despite some quarter-over-quarter improvements in net loss, Adjusted EBITDA, and a slight revenue increase.

Positives

• Net loss improved to $12.5 million in Q3 2025 from $18.7 million in Q2 2025.
• Adjusted EBITDA increased to $2.5 million in Q3 2025 from $1.9 million in Q2 2025.
• Revenue saw a slight quarter-over-quarter increase of $0.2 million from Q2 2025.

Negatives

• Revenue decreased by $4.9 million year-over-year from Q3 2024.
• Gross profit decreased by $2.5 million year-over-year from Q3 2024 and $0.6 million quarter-over-quarter from Q2 2025.
• Gross margin declined by 86 basis points year-over-year from Q3 2024 and 188 basis points quarter-over-quarter from Q2 2025.
• Net loss of $12.5 million in Q3 2025 was larger than the $11.6 million net loss in Q3 2024.
• Adjusted EBITDA decreased by $2.8 million year-over-year from Q3 2024.

Risks

• Forward-looking statements are subject to significant risks and uncertainty, including those set forth in the company's reports filed with the SEC and Canadian Securities Regulators.
• Ongoing legal disputes contribute to non-recurring charges.

Future Outlook

Forward-looking statements relate to the company's financial performance, business development, and results of operations, but no specific guidance or estimates for future periods are provided in this filing.

Industry Context

The filing reports the company's financial performance within the regulated cannabis industry in the United States, but does not provide specific analysis of broader industry trends or competitor performance.

Legal Proceedings

• The company is involved in ongoing legal disputes, contributing to non-recurring charges.

Stakeholder Impact

• Shareholders are impacted by the company's financial performance, including declining revenue and profitability year-over-year.

Key Dates

Recommendation

The company's Q3 2025 results show a concerning year-over-year decline across key financial metrics including revenue, gross profit, gross margin, and Adjusted EBITDA, alongside a larger net loss. While there are some quarter-over-quarter improvements in net loss and Adjusted EBITDA, the overall trend from the prior year suggests underlying challenges. A 'hold' recommendation is appropriate for a seasoned investor, indicating caution due to the negative year-over-year trends, but not an immediate 'sell' given the slight sequential improvements and without further strategic context or future guidance.

Keywords

cannabis, financial results, Q3 2025, revenue, gross profit, net loss, Adjusted EBITDA, cultivation, processing, dispensary